FURLAN, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 978
EU - Europa 937
AS - Asia 565
AF - Africa 3
SA - Sud America 2
Totale 2.485
Nazione #
US - Stati Uniti d'America 972
SE - Svezia 423
CN - Cina 273
SG - Singapore 246
RU - Federazione Russa 203
IT - Italia 147
FI - Finlandia 46
IE - Irlanda 35
DE - Germania 30
GB - Regno Unito 29
IN - India 11
NL - Olanda 11
FR - Francia 8
JP - Giappone 8
CA - Canada 5
IR - Iran 5
SA - Arabia Saudita 5
KR - Corea 4
EG - Egitto 3
HK - Hong Kong 3
TR - Turchia 3
PK - Pakistan 2
PL - Polonia 2
BR - Brasile 1
CL - Cile 1
CY - Cipro 1
ES - Italia 1
GR - Grecia 1
ID - Indonesia 1
JO - Giordania 1
KG - Kirghizistan 1
MX - Messico 1
TW - Taiwan 1
UA - Ucraina 1
Totale 2.485
Città #
Lawrence 174
Princeton 172
Ashburn 163
Singapore 159
Shanghai 132
Moscow 77
Milan 71
New York 52
Boardman 41
Helsinki 41
Washington 40
Dublin 35
Dallas 27
Los Angeles 18
Seattle 15
Guangzhou 14
Manchester 11
Rome 9
Xi'an 8
Pune 7
Shenzhen 7
Beijing 6
London 6
Amsterdam 5
Austin 5
Jeddah 5
Lappeenranta 5
Borås 4
Edgware 4
Harrow 4
Kunming 4
Santa Clara 4
Chions 3
Gronau 3
Qina 3
Tomblaine 3
Wuxi 3
Bergamo 2
Canneto sull'Oglio 2
Central 2
Chandigarh 2
Chaponnay 2
Chuo 2
Clifton 2
Florence 2
Foshan 2
Genoa 2
Hangzhou 2
Jiaxing 2
Karachi 2
Mapo-gu 2
Marseille 2
Munich 2
Naples 2
Phoenix 2
Quanzhou 2
Salford 2
San Mateo 2
Shinjuku 2
Toronto 2
Wuhan 2
's-Hertogenbosch 1
Andover 1
Arenzano 1
Belleville 1
Berlin 1
Bishkek 1
Brierley Hill 1
Carate Brianza 1
Cassolnovo 1
Castel Maggiore 1
Cernusco sul Naviglio 1
Chaozhou 1
Cheongju-si 1
Cheyenne 1
Chicago 1
Duncan 1
Ely 1
Enschede 1
Erlangen 1
Falkenstein 1
Friesland 1
Fuzhou 1
Giulianova 1
Gunzenhausen 1
Gurgaon 1
Halifax 1
Hong Kong 1
Houston 1
Indore 1
Jinhua 1
Kish 1
Leganés 1
Melikgazi 1
Mexico City 1
Montesilvano 1
Mount Vernon 1
Mountain View 1
Nantong 1
Napoli 1
Totale 1.427
Nome #
Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up 41
Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study 37
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 36
A peripheral inflammatory signature discriminates bipolar from unipolar depression: A machine learning approach 36
Clinical Features and Biomarkers to Differentiate Primary and Amyotrophic Lateral Sclerosis in Patients With an Upper Motor Neuron Syndrome 32
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 30
One-year mental health outcomes in a cohort of COVID-19 survivors 26
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 25
Neuroinflammation in Bipolar Depression 24
Neurofilaments light: Possible biomarker of brain modifications in bipolar disorder 24
Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder 23
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients 23
INCREASE OF MYELOID MICROVESICLES IN THE CEREBROSPINAL FLUID AS BIOMARKER OF MICROGLIA/MACROPHAGE ACTIVATION IN NEUROLOGICAL DISORDERS 21
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study 21
Ventilation With Argon Improves Survival With Good Neurological Recovery After Prolonged Untreated Cardiac Arrest in Pigs 20
Absence of oligoclonally restricted immunoglobulins in tears from multiple sclerosis patients 20
A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines 20
Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis 20
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life 20
ALTERED MRNA LEVELS OF CHEMOKINES AND CYTOKINES IN SCHIZOPHRENIA AND BIPOLAR DISORDER 19
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis 19
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 19
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 19
Dysregulation of MS risk genes and pathways at distinct stages of disease 19
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study 19
Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis 19
Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis 19
Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder 19
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects 18
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 18
DIFFERENTIAL miRNAs EXPRESSION PROFILE BETWEEN TREG-VERSUS T EFFECTOR CELLS IN COURSE OF MULTIPLE SCLEROSIS 18
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 18
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis 18
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 18
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis 18
CSF extracellular vesicles and risk of disease activity after a first demyelinating event 18
Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors 18
Gene transfer to pancreatic islets mediated by a replication incompetent HSV-1 17
Neuromyelitis optica spectrum disorder: the importance of NMO-IgG in clinical practice 17
Administration of an MCP-1 variant to EAE mice prevents inflammatory cell recruitment and protects from demyelination and axonal loss 17
ACID SPHINGOMYELINASE TRIGGERS P2X7-INDUCED MICROPARTICLE RELEASE FROM GLIAL CELLS 17
Cytokines and immunity in multiple sclerosis: the dual signal hypothesis 17
In vivo fate analysis reveals the multipotent and self-renewal features of embryonic AspM expressing cells 17
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes. 17
Stiff-man syndrome and autoimmunity; pathogenetic problems 17
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 17
Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients 17
miR-21 sustains CD28 signalling and low-affinity T-cell responses at the expense of self-tolerance 17
Classical and unconventional pathways of vesicular release in microglia 16
T regulatory cells are markers of disease activity in multiple sclerosis patients 16
Activation of invariant NKT cells by alpha GalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma 16
Natural Killer cells protect white matter integrity in Bipolar Disorder 16
Real time RT-PCR determination of mRNA levels of cytokine, chemokine and chemokine receptors in PBLs from MS patients: clinical and MRI correlations 16
Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs 16
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 16
Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer’s disease 16
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis 16
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: A 2-year study 16
Cxcl10 enhances blood cells migration in the sub-ventricular zone of mice affected by experimental autoimmune encephalomyelitis 15
Vitamin D levels and risk of developing multiple sclerosis 15
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates 15
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression 15
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes 15
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 14
Motor-evoked potentials (MEPs) for monitoring chronic cortico-spinal damage in MOG35-55-induced experimental autoimmune encephalomyelitis (EAE) 14
Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination 14
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 14
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndrome 14
Neural progenitor cells orchestrate microglia migration and positioning into the developing cortex 14
Lentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia 14
Cytokine gene delivery into the central nervous system using intrathecally injected non-replicative viral vectors 14
Animal models of multiple sclerosis 14
Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss 14
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 14
Synapsin I deletion reduces neuronal damage and ameliorates clinical progression of experimental autoimmune encephalomyelitis 14
LONG-TERM DISEASE CONTROL OF REFRACTORY NEUROMYELITIS OPTICA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 14
Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis. 14
2D immunomic approach for the study of IgG autoantibodies in the experimental model of multiple sclerosis 14
The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms 13
B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis 13
Evaluation of different techniques to detect anti-acquaporin 4 antibodies in neuromyelitis optica patients 13
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis 13
Inflammation affects striatal glutamate transmission since the pre-clinical phase of experimental autoimmune encephallonlyelitis 13
Clinical and functional recovery from experimental autoimmune encephalomyelitis by intracisternal delivery of IL4 from a helper-dependent adenoviral vector. A pre-clinical model of gene therapy of multiple sclerosis 13
MICROVESICLES IN THE CEREBROSPINAL FLUID REFLECT MICROGLIA/MACROPHAGE ACTIVATION IN RODENT AND HUMAN NEURO-INFLAMMATION 13
Method for intracellular labeling of lymphocytes using Endorem(R) and Feridex(R): Possible applications for MRI studies in multiple sclerosis (MS) 13
Similar low frequency of anit-MOG IgG and IgM in MS patients and healthy subjects 13
Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment. 13
Artificial intelligence techniques in the diagnosis of multiple sclerosis 13
Prognostic Value of Vitamin D in Clinically Isolated Syndromes (CIS) 13
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 13
A helper dependent adenovirus efficiently delivers bioactive FGF-II to the CNS 12
Opposite changes of glutamate and GABA transmission in the striatum of mice with experimental autoimmune encephalomyelitis 12
A model of HTLV-I infection in the SCID mouse 12
Adenovirus-mediated IL-4 transfer is protective in ischemia/reperfusion brain injury 12
Evaluation of different techniques to detect anti-aquaporin 4 antibodies 12
Mesenchymal stem cells as treatment for multiple sclerosis: Immunomodulation versus tissue repair 12
Acid sphingomyelinase activity triggers microparticle release from glial cells 12
Subclinical central inflammation is risk for RIS and CIS conversion to MS 12
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 12
Totale 1.741
Categoria #
all - tutte 52.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.759


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 6 0 1
2020/202118 0 0 0 3 0 0 5 0 8 0 2 0
2021/2022162 6 4 1 57 14 18 16 5 7 15 7 12
2022/20231.070 398 175 50 6 8 85 37 49 28 24 201 9
2023/2024784 7 44 108 61 103 174 20 62 8 26 34 137
2024/2025698 376 68 54 94 106 0 0 0 0 0 0 0
Totale 2.798